bioRxiv Science⌕ Search

Biology subjects

Cruz-Cortes, C.

Publications and source records attributed to Cruz-Cortes, C..

3 recordsLinked to original sources

Supercharging the calcium pump: Identification of an activation hotspot on SERCA by cryo-EM.

The sarco-endoplasmic reticulum Ca{superscript 2}-ATPase (SERCA) is a ubiquitous P-type ATPase that restores cytosolic Ca2+ to the sarco-endoplasmic reticulum. SERCA is essential for cardiac Ca2+ cycling and cellular energy metabolism. Several small molecules enhance SERCA function and show promise in models of metabolic and cardiovascular diseases. However, the structural basis for SERCA activation has remained unknown, hindering mechanism-driven lead optimization. Here we present cryo-EM structures of SERCA bound to two chemically distinct activators: the quinoline derivative CDN1163 (2.6 [A] resolution) and a benzofuran derivative UM-52 (3.1 [A] resolution). Biochemical assays show that both compounds stimulate Ca2+-dependent ATPase activity of SERCA without altering the apparent Ca{superscript 2} affinity. The structures reveal a previously unrecognized "activation hotspot" in the transmembrane domain, a shallow groove formed by helices M3 and M4 and capped by M1. Despite low chemical similarity, both activators occupy the same pocket and share conserved interactions with Ser265, Trp272, and Phe296. These residues are unique to SERCA and help explain selectivity relative to other P-type ATPases. Activator binding stabilizes a catalytically competent conformation, shifting SERCA toward an E1-like state poised for ATP binding and coordinated movements of the M1-M4 bundle and the cytosolic domains. Notably, density consistent with a detergent acyl chain bridges an otherwise open cavity adjacent to the compound, suggesting that altered protein-lipid interactions may contribute to activation. Together, these findings define a structural framework for SERCA activation and provide a blueprint for rational design of next-generation SERCA activators. SIGNIFICANCE STATEMENTSERCA pumps Ca{superscript 2} into the sarco-endoplasmic reticulum, enabling muscle relaxation and shaping calcium signals across tissues. Small-molecule SERCA activators improve cardiac and metabolic phenotypes in animal models, but drug development has been limited by the absence of a defined binding site and activation mechanism. We determined cryo-EM structures of SERCA bound to two distinct activators, CDN1163 and UM-52. Both compounds occupy a groove formed by transmembrane segments M3-M4, anchored by a hydrogen bond to the SERCA-specific Ser265 and aromatic contacts near Trp272 and Phe296. An acyl chain bridges a gap in the binding pocket toward M1, suggesting that protein-lipid coupling may play a role in SERCA activation. These results directly enable structure-mechanism guided design of next-generation selective SERCA activators.

biophysics↗

Paradoxical SERCA dysregulation contributes to atrial fibrillation in a model of diet-induced obesity

Obesity is a major risk factor for atrial fibrillation (AF) the most common serious cardiac arrhythmia, but the molecular mechanisms underlying diet-induced AF remain unclear. In this study, we subjected mice to a chronic high-fat diet and acute sympathetic activation ( two-hit model) to study the mechanisms by which diet-induced obesity promotes AF. Surface electrocardiography revealed that diet-induced obesity and sympathetic activation synergize during intracardiac tachypacing to induce AF. At the cellular level, diet-induced obesity and acute adrenergic stimulation facilitate the formation of delayed afterdepolarizations in atrial myocytes, implicating altered Ca2+ dynamics as the underlying cause of AF. We found that diet-induced obesity does not alter the expression of major Ca2+-handling proteins in atria, including the sarcoplasmic reticulum Ca2+-ATPase (SERCA), a major component of beat-to-beat Ca2+ cycling in the heart. Paradoxically, obesity reduces phospholamban phosphorylation, suggesting decreased SERCA activity, yet atrial myocytes from obese mice showed a significantly increased Ca2+ transient amplitude and SERCA-mediated Ca2+ uptake. Adrenergic stimulation further increases the Ca2+ transient amplitude but does not affect Ca2+ reuptake in atrial myocytes from obese mice. Transcriptomics analysis showed that a high-fat diet prompts upregulation of neuronatin, a protein that has been implicated in obesity and is known to stimulate SERCA activity. We propose a mechanism in which obesity primes SERCA for paradoxical activation, and adrenergic stimulation facilitates AF conversion through a Ca2+-induced Ca2+ release gain in atrial myocytes. Overall, this study links obesity, altered Ca2+ signaling, and AF, and targeting this mechanism may prove effective for treating obesity-induced AF.

physiology↗

Activation mechanism of the cardiac calcium pump by a small-molecule allosteric modulator

The discovery of small-molecule allosteric modulators is an emerging paradigm in drug discovery, and signal transduction is a subtle and dynamic process that is challenging to characterize. We developed a time-correlated single photon counting (TCSPC) imaging approach to investigate the activation mechanism of a druggable protein by a small-molecule allosteric modulator. We tested this approach using the cardiac sarcoplasmic reticulum Ca2+-ATPase (SERCA2a), an important pharmacological target that transports Ca2+ at the expense of ATP hydrolysis in the heart. We found that CDN1163, a validated SERCA2a activator, does not dissociate the endogenous complex between SERCA2a and its regulator phospholamban (PLN) in the presence of either Ca2+ or AMP-PCP, a non-hydrolyzable ATP analog. CDN1163 does not influence SERCA2as affinity for Ca2+ ions at functionally relevant conditions. Global analysis of the fluorescence lifetimes showed that ATP is both a substrate and a modulator that populates competent SERCA2a conformations. Interestingly, CDN1163 alone does not significantly induce changes in the structural populations of SERCA2a. Instead, CDN1163 potentiates the effects of ATP to further shift the equilibrium toward a competent SERCA2a conformation. Importantly, this population shift occurs at sub-physiological conditions, and within physiological Ca2+ concentrations at which SERCA2a operates. We propose an activation mechanism whereby a small-molecule modulator synergizes with ATP to stabilize a conformation of SERCA2a primed for activation. This study demonstrates the power of TCSPC to reveal novel insights into how structural and biochemical states are coupled to allosterically activate a pharmacological target in the heart.

biophysics↗